LSV Asset Management
IRWD icon

LSV Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

LSV Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Hold
308,271
– – ﹤0.01% 642
2026
Q1 		$1.08M Buy
308,271
+299,223
+3,307% +$1.23M ﹤0.01% 628
2025
Q4 		$30K Buy
+9,048
New +$23.5K ﹤0.01% 860
2025
Q3 		– Sell
-2,750,200
Closed -$1.97M – 904
2025
Q2 		$1.97M Sell
2,750,200
-1,247,601
-31% -$979K ﹤0.01% 557
2025
Q1 		$5.88M Sell
3,997,801
-83,700
-2% -$199K 0.01% 460
2024
Q4 		$18.1M Sell
4,081,501
-970,100
-19% -$3.94M 0.04% 329
2024
Q3 		$20.8M Sell
5,051,601
-1,019,900
-17% -$5.48M 0.04% 312
2024
Q2 		$39.6M Sell
6,071,501
-79,500
-1% -$562K 0.09% 237
2024
Q1 		$53.6M Sell
6,151,001
-631,100
-9% -$7.66M 0.11% 210
2023
Q4 		$77.6M Sell
6,782,101
-382,108
-5% -$3.78M 0.17% 172
2023
Q3 		$69M Sell
7,164,209
-506,100
-7% -$4.96M 0.16% 177
2023
Q2 		$81.6M Buy
7,670,309
+92,600
+1% +$995K 0.18% 168
2023
Q1 		$79.7M Sell
7,577,709
-348,688
-4% -$3.91M 0.18% 163
2022
Q4 		$98.2M Buy
7,926,397
+12,177
+0.2% +$138K 0.22% 145
2022
Q3 		$82M Buy
7,914,220
+435,063
+6% +$4.93M 0.19% 153
2022
Q2 		$86.2M Buy
7,479,157
+71,827
+1% +$846K 0.19% 157
2022
Q1 		$93.2M Sell
7,407,330
-100,076
-1% -$1.15M 0.17% 161
2021
Q4 		$87.5M Sell
7,507,406
-304,821
-4% -$3.74M 0.16% 171
2021
Q3 		$102M Buy
7,812,227
+3,448,000
+79% +$44.6M 0.18% 155
2021
Q2 		$56.2M Buy
4,364,227
+3,390,228
+348% +$38.8M 0.1% 221
2021
Q1 		$10.9M Buy
+973,999
New +$10.3M 0.02% 454

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

LSV Asset Management's IRWD Position: Q2 2026 in Review

LSV Asset Management held its Ironwood Pharmaceuticals (IRWD) position steady in Q2 2026 at 308,271 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #642.

LSV Asset Management first reported a position in IRWD in Q1 2021 and has held it in 21 quarters since. The position peaked at $102M in Q3 2021. 80 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • LSV Asset Management held 308,271 shares of Ironwood Pharmaceuticals worth $1.3M as of Q2 2026.
  • LSV Asset Management left its Ironwood Pharmaceuticals share count unchanged in Q2 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of LSV Asset Management's portfolio in Q2 2026, its #642 holding.
  • LSV Asset Management first reported a position in Ironwood Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • LSV Asset Management's Ironwood Pharmaceuticals position peaked at $102M in Q3 2021.
  • 80 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.